Dermatologicals in China

 Published On: Oct, 2017 |    No of Pages: 18 |  Published By: Euromonitor | Format: PDF
Request Free Sample
Dermatologicals is expected to witness a further slowdown in value sales growth at constant 2017 prices over the forecast period. Regional factors play a role in the sales of various dermatologicals. For instance, antifungals are more commonly purchased in southern and eastern China, where the weather is more humid, while antipruritics are more likely to be bought in northern and western China, where the air is dry. However, the incidence of skin ailments is expected to decline thanks to improvi...

Dermatologicals in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the marketís major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

DERMATOLOGICALS IN CHINA

Headlines
Prospects
Changing Lifestyles and Trading Up To Better Quality Products Leading To A Slowdown in Growth
New Distribution Model Set To Improve the Efficiency of Pharmacies
Competitive Landscape
Xian Janssen Pharmaceutical Ltd Continues To Lead Dermatologicals Thanks To Strong Brands and Proactive Marketing
Leading Companies Generally Outperform Smaller Players
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Continues To Perform Well
Healthcare Reform Policies Heavily Impact the Industry
Mergers and Acquisitions Reshape the Competitive Landscape
Omni-channel Distribution Is Emerging in Consumer Health
Stable Growth Anticipated
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017
Market Data
Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2016-2017
Definitions
Sources
Summary 2 Research Sources

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.